Author： Diamantopoulos Alex
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.30, Iss.10, 2012-10, pp. : 977-977
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Ramipril, rosiglitazone for atherosclerosis: STARR results?
Inpharma, Vol. 1, Iss. 1585, 2007-01 ,pp. :
Access to resources
Recommend
Prescribing HRT to change following trial results?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 384, 2002-01 ,pp. :
Cost-benefit or cost-utility analysis?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 315, 2001-01 ,pp. :
A ready remedy for rheumatoid arthritis realised in R 788 results?
Inpharma, Vol. 1, Iss. 1619, 2008-01 ,pp. :